The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doyle John Brendan since 2026.
This trader's CIK number is 1840738.
At the time of last reporting, Doyle John Brendan was the Chief Financial Officer of Cognition Therapeutics Inc. (stock ticker symbol CGTX).
Also see all insider trading activities at Cognition Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CGTX | 10,000 | $11,299 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-16 | CGTX | Buy | 10,000 | 1.13 | 11,299 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doyle John Brendan (Chief Financial Officer of Cognition Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.